Form 4: BioAffinity Technologies Director Exercises Stock Options, Disposes of Shares
SEC Form 4 Filing
Robert A. Anderson, a director at bioAffinity Technologies, exercised stock options and disposed of 64,848 common stock shares on February 26, 2024.
Summary
- On February 26, 2024, Robert A. Anderson, a director of bioAffinity Technologies, Inc. (BIAF), exercised stock options to acquire 64,848 shares of common stock at a price of $1.115 per share.
- Simultaneously, Anderson disposed of 64,848 shares of common stock at a price of $1.155.
- Following these transactions, Anderson directly owns 121,856 shares of bioAffinity Technologies.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- The transaction provides information to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Date of stock option exercise and share disposal. |
| 03/29/2024 | Date of Form 4 filing. |
Keywords
Form 4, bioAffinity Technologies, BIAF, stock options, Robert A. Anderson, director, share disposal, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.